Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Genet., 01 December 2025

Sec. Genetics of Common and Rare Diseases

Volume 16 - 2025 | https://doi.org/10.3389/fgene.2025.1749030

Correction: MAPT mutation-induced behavioral variant frontotemporal dementia in an Asian patient: a multimodal biomarker case report resolving diagnostic challenges with Alzheimer’s disease

Yan Zhang&#x;Yan Zhang1Siwei Chen&#x;Siwei Chen1Guiying YanGuiying Yan2Zhifei ZhangZhifei Zhang1 Amina Amina1Ting WangTing Wang1Shuang WangShuang Wang1Chen ZhangChen Zhang1Yong&#x;an Sun
Yong’an Sun1*
  • 1Department of Neurology, Peking University First Hospital, Beijing, China
  • 2Academy of Mathematics and Systems Science, Chinese Academy of Sciences, Beijing, China

In the published article, the Acknowledgments section was omitted. The Acknowledgement section appears below.

The authors are thankful to the patient and her family for allowing us to share this case. We would like to express our gratitude to Dr. Meng Yu for referring the patient and to the patient’s family for their active cooperation during the diagnosis and treatment process, which significantly facilitated the smooth progression of the clinical workflow.

The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: frontotemporal dementia, MAPT mutation, biomarkers, cross-culturaldiagnosis, NMDA receptor antagonist

Citation: Zhang Y, Chen S, Yan G, Zhang Z, Amina , Wang T, Wang S, Zhang C and Sun Y (2025) Correction: MAPT mutation-induced behavioral variant frontotemporal dementia in an Asian patient: a multimodal biomarker case report resolving diagnostic challenges with Alzheimer’s disease. Front. Genet. 16:1749030. doi: 10.3389/fgene.2025.1749030

Received: 18 November 2025; Accepted: 19 November 2025;
Published: 01 December 2025.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2025 Zhang, Chen, Yan, Zhang, Amina, Wang, Wang, Zhang and Sun. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Yong’an Sun, c3lhNzVAMTYzLmNvbQ==

These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.